OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of Novel NLRP3 Inflammasome Inhibitors Composed of an Oxazole Scaffold Bearing an Acylsulfamide
Yusuke Ohba, K. Adachi, Takayuki Furukawa, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1833-1838
Closed Access | Times Cited: 5
Yusuke Ohba, K. Adachi, Takayuki Furukawa, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1833-1838
Closed Access | Times Cited: 5
Showing 5 citing articles:
Screening novel anti-inflammatory peptides inhibiting the NLRP3 inflammasome from UHPLC-MS/MS-characterized peptide profiles of cocoa tea protein hydrolysates
Hai-Biao Gong, Chang‐Yu Yan, Hui-Er Ye, et al.
Food Research International (2025), pp. 116519-116519
Closed Access
Hai-Biao Gong, Chang‐Yu Yan, Hui-Er Ye, et al.
Food Research International (2025), pp. 116519-116519
Closed Access
Houttuynia cordata-Derived Exosome-Like Nanoparticles Mitigate Colitis in Mice via Inhibition of the NLRP3 Signaling Pathway and Modulation of the Gut Microbiota
Jianhong Li, Jing Xu, Chen Huang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13991-14018
Open Access | Times Cited: 3
Jianhong Li, Jing Xu, Chen Huang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13991-14018
Open Access | Times Cited: 3
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
Rosalie Matico, Karolien Grauwen, Dhruv Chauhan, et al.
EMBO Molecular Medicine (2024) Vol. 17, Iss. 1, pp. 54-84
Closed Access | Times Cited: 1
Rosalie Matico, Karolien Grauwen, Dhruv Chauhan, et al.
EMBO Molecular Medicine (2024) Vol. 17, Iss. 1, pp. 54-84
Closed Access | Times Cited: 1
Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome
Sherihan El‐Sayed, Emily McMahon, Sondos Musleh, et al.
Bioorganic Chemistry (2024), pp. 107909-107909
Open Access
Sherihan El‐Sayed, Emily McMahon, Sondos Musleh, et al.
Bioorganic Chemistry (2024), pp. 107909-107909
Open Access
Synthesis, biological evaluation and molecular dynamics simulations of new sulfonylurea derivatives bearing biphenyl moieties as potential NLRP3 inhibitors
Xin Xiong, Ruifeng Zhang, Zhijian Min, et al.
Research on Chemical Intermediates (2024) Vol. 50, Iss. 12, pp. 5863-5883
Closed Access
Xin Xiong, Ruifeng Zhang, Zhijian Min, et al.
Research on Chemical Intermediates (2024) Vol. 50, Iss. 12, pp. 5863-5883
Closed Access
Synthesis of novel sulfamides derived from dopamine analogues with their in silico studies against hyperprolactinemia
Süleyman Göksu, Ali Naderi, Ahmet Çağan, et al.
Organic Communications (2024), Iss. 4, pp. 205-217
Open Access
Süleyman Göksu, Ali Naderi, Ahmet Çağan, et al.
Organic Communications (2024), Iss. 4, pp. 205-217
Open Access
